Share
Market Research Report

EUROPE, ASIA PACIFIC, LATIN AMERICA, MIDDLE EAST & AFRICA URINARY TRACT INFECTION (UTI) VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Vaccine TypeBacterial whole-cell Vaccines · Subunit Vaccines · Conjugate Vaccines · Live-Attenuated Vaccines · Others
  • By Pathogen TargetedEscherichia coli · Klebsiella pneumoniae · Pseudomonas aeruginosa · Other Targeted Pathogens
  • By Age GroupPediatric · Adults · Elderly
  • By Route of AdministrationParenteral · Oral · Sublingual · Intranasal
  • By Sales ChannelHospitals and Clinic Pharmacies · Retail pharmacies · Others
  • Published In27 Aug 2026
  • Report CodeCMI10009
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Vaccine Type
      • Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Pathogen Targeted
      • Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Age Group
      • Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Route of Administration
      • Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Sales Channel
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trends
  4. Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Vaccine Type, 2021-2033, (USD Th)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Bacterial whole-cell Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Subunit Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Conjugate Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Live-Attenuated Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
  5. Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Pathogen Targeted, 2021-2033, (USD Th)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Escherichia coli
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Klebsiella pneumoniae
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Pseudomonas aeruginosa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Other Targeted Pathogens
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
  6. Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Age Group, 2021-2033, (USD Th)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Adults
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Elderly
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
  7. Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Route of Administration, 2021-2033, (USD Th)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Sublingual
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Intranasal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
  8. Europe, Asia Pacific, Latin America, Middle East & Africa Urinary Tract Infection (UTI) Vaccine Market, By Sales Channel, 2021-2033, (USD Th)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals and Clinic Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Retail pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Th)
  9. Competitive Landscape

    • INMUNOTEK S.L.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • OM Pharma SA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sequoia Vaccines, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline Biologicals SA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Strathmann GmbH & Co. KG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Legacy Pharmaceuticals Switzerland GmbH
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CureVac SE
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Janssen-Cilag International NV
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlycoVaxyn AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Urinary Tract Infection (UTI) Vaccine Market’– Europe, Asia Pacific, Latin America, Middle East & Africa forecast to 2033